Praxis Precision Medicines (PRAX) Competitors $33.79 +3.96 (+13.28%) Closing price 04:00 PM EasternExtended Trading$33.84 +0.05 (+0.16%) As of 06:19 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PRAX vs. ALVO, APLS, SRRK, CRNX, IMVT, ACAD, VKTX, XENE, IBRX, and AMRXShould you be buying Praxis Precision Medicines stock or one of its competitors? The main competitors of Praxis Precision Medicines include Alvotech (ALVO), Apellis Pharmaceuticals (APLS), Scholar Rock (SRRK), Crinetics Pharmaceuticals (CRNX), Immunovant (IMVT), ACADIA Pharmaceuticals (ACAD), Viking Therapeutics (VKTX), Xenon Pharmaceuticals (XENE), ImmunityBio (IBRX), and Amneal Pharmaceuticals (AMRX). These companies are all part of the "pharmaceutical products" industry. Praxis Precision Medicines vs. Alvotech Apellis Pharmaceuticals Scholar Rock Crinetics Pharmaceuticals Immunovant ACADIA Pharmaceuticals Viking Therapeutics Xenon Pharmaceuticals ImmunityBio Amneal Pharmaceuticals Praxis Precision Medicines (NASDAQ:PRAX) and Alvotech (NASDAQ:ALVO) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, analyst recommendations, community ranking, media sentiment, profitability, institutional ownership, risk, dividends and earnings. Which has more risk and volatility, PRAX or ALVO? Praxis Precision Medicines has a beta of 2.66, indicating that its share price is 166% more volatile than the S&P 500. Comparatively, Alvotech has a beta of -0.05, indicating that its share price is 105% less volatile than the S&P 500. Which has stronger earnings & valuation, PRAX or ALVO? Praxis Precision Medicines has higher earnings, but lower revenue than Alvotech. Alvotech is trading at a lower price-to-earnings ratio than Praxis Precision Medicines, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPraxis Precision Medicines$8.55M70.32-$123.28M-$10.27-2.90Alvotech$489.68M5.12-$551.73M-$0.87-9.56 Do analysts rate PRAX or ALVO? Praxis Precision Medicines presently has a consensus target price of $123.33, suggesting a potential upside of 313.45%. Alvotech has a consensus target price of $18.00, suggesting a potential upside of 116.35%. Given Praxis Precision Medicines' higher possible upside, equities analysts clearly believe Praxis Precision Medicines is more favorable than Alvotech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Praxis Precision Medicines 1 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.78Alvotech 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media favor PRAX or ALVO? In the previous week, Alvotech had 1 more articles in the media than Praxis Precision Medicines. MarketBeat recorded 8 mentions for Alvotech and 7 mentions for Praxis Precision Medicines. Praxis Precision Medicines' average media sentiment score of 1.19 beat Alvotech's score of -0.05 indicating that Praxis Precision Medicines is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Praxis Precision Medicines 4 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Alvotech 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Does the MarketBeat Community believe in PRAX or ALVO? Praxis Precision Medicines received 43 more outperform votes than Alvotech when rated by MarketBeat users. Likewise, 74.63% of users gave Praxis Precision Medicines an outperform vote while only 50.00% of users gave Alvotech an outperform vote. CompanyUnderperformOutperformPraxis Precision MedicinesOutperform Votes5074.63% Underperform Votes1725.37% AlvotechOutperform Votes750.00% Underperform Votes750.00% Do insiders and institutionals hold more shares of PRAX or ALVO? 67.8% of Praxis Precision Medicines shares are held by institutional investors. 2.7% of Praxis Precision Medicines shares are held by insiders. Comparatively, 0.5% of Alvotech shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Is PRAX or ALVO more profitable? Alvotech has a net margin of -123.47% compared to Praxis Precision Medicines' net margin of -9,409.22%. Alvotech's return on equity of 0.00% beat Praxis Precision Medicines' return on equity.Company Net Margins Return on Equity Return on Assets Praxis Precision Medicines-9,409.22% -54.86% -50.52% Alvotech -123.47%N/A -35.87% SummaryPraxis Precision Medicines beats Alvotech on 11 of the 18 factors compared between the two stocks. Remove Ads Get Praxis Precision Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for PRAX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PRAX vs. The Competition Export to ExcelMetricPraxis Precision MedicinesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$601.46M$6.27B$5.29B$7.35BDividend YieldN/A3.24%5.11%4.32%P/E Ratio-2.906.6921.6917.68Price / Sales70.32222.71373.8892.91Price / CashN/A65.6738.1534.64Price / Book3.775.776.353.94Net Income-$123.28M$142.01M$3.20B$247.45M7 Day Performance4.78%5.79%3.94%3.17%1 Month Performance-23.38%-15.47%-10.35%-8.53%1 Year Performance-41.26%-10.99%10.24%0.31% Praxis Precision Medicines Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PRAXPraxis Precision Medicines2.9665 of 5 stars$33.79+13.3%$123.33+265.0%-43.1%$681.31M$8.55M-3.28110Gap DownALVOAlvotech1.5444 of 5 stars$8.32-2.1%$18.00+116.3%-34.6%$2.51B$489.68M-4.501,026Analyst RevisionGap DownAPLSApellis Pharmaceuticals4.1263 of 5 stars$19.80-0.9%$45.59+130.2%-65.0%$2.49B$781.37M-9.75770Analyst RevisionPositive NewsSRRKScholar Rock3.8865 of 5 stars$26.04-3.2%$42.67+63.9%+112.6%$2.47B$33.19M-11.08140Positive NewsCRNXCrinetics Pharmaceuticals3.5961 of 5 stars$26.38-1.9%$73.00+176.7%-32.0%$2.45B$1.04M-7.07210IMVTImmunovant2.2129 of 5 stars$14.39-1.3%$41.00+184.9%-51.2%$2.44BN/A-5.49120Short Interest ↑Positive NewsACADACADIA Pharmaceuticals4.019 of 5 stars$14.61-5.0%$23.93+63.8%-14.7%$2.44B$957.80M18.73510VKTXViking Therapeutics4.2623 of 5 stars$21.28-5.9%$95.18+347.3%-65.3%$2.39BN/A-21.2820Upcoming EarningsAnalyst ForecastOptions VolumeNews CoverageGap DownXENEXenon Pharmaceuticals2.7559 of 5 stars$30.63+4.2%$57.38+87.3%-18.6%$2.34B$9.43M-10.86210Analyst DowngradeOptions VolumeAnalyst RevisionNews CoveragePositive NewsHigh Trading VolumeIBRXImmunityBio1.9412 of 5 stars$2.72-3.9%$12.19+348.1%-49.6%$2.32B$14.75M-2.96590Analyst ForecastNews CoverageHigh Trading VolumeAMRXAmneal Pharmaceuticals3.243 of 5 stars$7.21-2.3%$10.80+49.8%+31.7%$2.23B$2.79B-10.607,600Short Interest ↑Positive NewsGap Up Remove Ads Related Companies and Tools Related Companies Alvotech Competitors Apellis Pharmaceuticals Competitors Scholar Rock Competitors Crinetics Pharmaceuticals Competitors Immunovant Competitors ACADIA Pharmaceuticals Competitors Viking Therapeutics Competitors Xenon Pharmaceuticals Competitors ImmunityBio Competitors Amneal Pharmaceuticals Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PRAX) was last updated on 4/17/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Praxis Precision Medicines, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Praxis Precision Medicines With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PRAX Stock Free PRAX Stock Alerts